Join Now

Yearly Archives: 2020

Johnson & Johnson Signs Communiqué on Expanded Global Access for COVID-19

By Denise Bell | Published October 9, 2020

Johnson & Johnson recently announced that it’s joined 15 other companies in signing a Communiquie on Expanded Global Access to ensure that people everywhere – regardless of their income level – have access to COVID-19 vaccines, therapeutics and diagnostics under development at these companies.  Each of the signing companies—AstraZeneca; Bayer; bioMérieux; Boehringer Ingelheim; Bristol Myers […]

Posted in COVID-19 Updates, Industry News | Leave a comment

U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology

By Denise Bell | Published October 9, 2020

U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center. This new centralized office builds on the work by the Center for Technology & Venture Commercialization (TVC) and will facilitate the U’s efforts to drive technology commercialization and economic […]

Posted in BioUtah News, State News, Utah's Life Sciences Companies | Leave a comment

Xenocor Granted Breakthrough Technology Agreement with Premier Inc.

By admin | Published October 9, 2020

Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY, October 5, 2020–– Xenocor, Inc. offering the world’s first disposable articulating laparoscope, has received a group purchasing agreement with Premier Inc. for their single use Xenoscope™, in the surgical disposable scope category. The Xenocor disposable laparoscopic system […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

Mountain Pacific Venture Fund Invests in Laparoscopic Device Company Xenocor

By admin | Published October 9, 2020

For Immediate Release Xenocor’s single-use laparoscope, Xenoscope, increases access to minimally invasive surgical care Salt Lake City, October 5, 2020 – Mountain Pacific Venture Fund (MPVF) announced an investment in Xenocor, a Salt Lake City, Utah-based medical device company that has developed the Xenoscope™, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives

By Denise Bell | Published October 2, 2020

Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized by Utah Business Magazine as among Utah’s top C-Suite executives. In introducing the 2020 CXO of the Year honorees, the magazine notes that “now more than ever we need strong leaders to guide our businesses forward and […]

Posted in BioUtah News, Industry News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

Foldax Named Finalist in the Fierce Innovation Awards

By Denise Bell | Published October 2, 2020

Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020, a peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma. The company was selected as a finalist for its innovative TriaTM heart valve. The Tria valve reimagines the heart valve by incorporating a new, […]

Posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

Trump Administration Issues Final Drug Importation Rule

By Denise Bell | Published October 2, 2020

On September 24, the Trump Administration released a final rule to allow the importation of prescription drugs from Canada. The final rule follows a notice of proposed rule making last December, in which HHS outlined two potential pathways for importation. The first called the Section 804 Importation Program, is established under the final rule, while […]

Posted in Policy News | Leave a comment

Alucent Biomedical Announces $35 Million Series B Financing

By Denise Bell | Published October 2, 2020

Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is treated, yesterday announced the close of a $35 million Series B financing round. The funding will support two clinical trials to evaluate Alucent’s novel treatment for peripheral artery disease (PAD) of the lower extremities. PAD is a […]

Posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration

By Denise Bell | Published September 25, 2020

IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung Test™ for lung cancer has been formally accepted for submission to China’s National Medical Products Administration (NMPA), formerly known as the Chinese Food and Drug Administration (CFDA).  Mr. Jared Bauer, IONIQ Sciences CEO, stated, “We are excited […]

Posted in BioUtah News, Utah's Life Sciences Companies | Leave a comment

J&J Enters Phase 3 Trial for COVID-19 Vaccine

By Denise Bell | Published September 25, 2020

BioUtah member Johnson & Johnson (J&J) announced that they’ve started the global phase 3 trial of Janssen’s single-dose vaccine candidate, following phase 1/2 studies that demonstrated safety and immunogenicity.  “As COVID-19 continues to impact the daily lives of people around the world, our goal remains the same – leveraging the global reach and scientific innovation […]

Posted in BioUtah COVID-19 Analysis, Federal News, Industry News | Leave a comment

SDP Oncology Announces New Data from Phase 1 Solid Tumor Study

By Denise Bell | Published September 25, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase 1 study evaluating dubermatinib (TP-0903) in patients with advanced solid tumors.  “These preliminary data presented at ESMO 2020 are encouraging as we learn more about how dubermatinib may inhibit the AXL kinase protein and sensitize cancer cells […]

Posted in BioUtah News, Utah's Life Sciences Companies | Leave a comment

President Trump Signs Executive Order on Healthcare, Pre-existing Conditions

By Denise Bell | Published September 25, 2020

During a campaign event yesterday in Charlotte, North Carolina, President Trump signed an executive order on a range of health issues, including protecting people with pre-existing medical conditions, lowering prescription drug costs, increasing consumer choice, and providing greater transparency. The order also directs HHS Secretary Alex Azar to work with Congress to pass legislation to […]

Posted in Federal News, Policy News | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members